MedTrace Logo

Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B

NCT02533544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 572

Last updated 2019-01-30

No results posted yet for this study

Summary

This is an open-label, single arm cohort study to see efficacy and safety of tenofovir disoproxil fumarate (TDF) in naïve chronic hepatitis B, retrospectively and prospectively both.

Conditions

Interventions

DRUG

tenofovir disoproxil fumarate

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • Wonkwang University

    collaborator OTHER

  • Soonchunhyang University Hospital

    collaborator OTHER

  • Chungnam National University Hospital

    collaborator OTHER

  • Konyang University Hospital

    collaborator OTHER

  • Myeong Jun Song

    lead OTHER

Principal Investigators

  • Myeong Jun Song, Ph.D. M.D. · The Catholic University of Korea

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • South Korea

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02533544 on ClinicalTrials.gov